If you enjoy this content, please share it with a colleague
RELATED CONTENT
Study findings presented during the San Antonio Breast Cancer Symposium (SABCS) in December, stating that brachytherapy was associated with a twofold increased risk for mastectomy and complications, garnered almost immediate reaction from several industry groups, questioning that claim.
October 21, 2011 — When we think about breast cancer, most of us think of it as a disease only affecting women. The truth is, about 2,140 new cases of invasive breast cancer will be diagnosed among men this year, according to the American Cancer Society.
May 9, 2011 - Initial findings from the SAVI Collaborative Research Project (SCRP), on SAVI radiation therapy for breast cancer, were presented at the recent annual meeting of the American Brachytherapy Society (ABS).
Cianna Medical has successfully completed a funding round totaling $12 million. Investor proceeds will be used to expand sales and marketing programs for the SAVI breast brachytherapy applicator.
September 28, 2010 — SAVI Sisters, a program designed to provide education about breast cancer treatment options, primarily through social networking, has been launched.
December 17, 2009 - Partial breast irradiation "is an approach that may allow more patients to undergo breast-conserving therapy more quickly, at lower cost, and with less risk of long-term complications,” said The American College of Surgeons (ACS) in a consensus statement.*
May 20, 2009 - Breast cancer radiation with the SAVI applicator provides positive cosmetic outcomes and the multicatheter device allows greater planning flexibility, technically easier insertion, according to two new studies on breast conservation therapy patients with small breasts, small tumor beds and minimal distance between the lumpectomy cavity and skin surface.
April 23, 2009 - A new study shows that the SAVI applicator, a small, expandable device inserted inside the breast to deliver partial breast irradiation, carries a low infection risk, a potential complication of such devices.
April 8, 2009 - Cianna Medical said it has successfully completed a funding round totaling more than $10 million to further accelerate commercialization of the company’s proprietary SAVI technology for breast cancer brachytherapy.
March 24, 2009 - Cianna Medical said today that the U.S. Patent and Trademark Office issued two patents that are directly related to its SAVI multi-catheter brachytherapy device for the treatment of breast cancer.